ATE212841T1 - Yohimbine und arginin enthaltende zusammensetzung zur behandlung der erektilen fehlfunktion - Google Patents
Yohimbine und arginin enthaltende zusammensetzung zur behandlung der erektilen fehlfunktionInfo
- Publication number
- ATE212841T1 ATE212841T1 AT98935102T AT98935102T ATE212841T1 AT E212841 T1 ATE212841 T1 AT E212841T1 AT 98935102 T AT98935102 T AT 98935102T AT 98935102 T AT98935102 T AT 98935102T AT E212841 T1 ATE212841 T1 AT E212841T1
- Authority
- AT
- Austria
- Prior art keywords
- arginine
- erectile dysfunction
- treatment
- composition containing
- yohimbine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9708504A FR2765483B1 (fr) | 1997-07-04 | 1997-07-04 | Medicament destine a traiter les dysfonctions erectiles |
| PCT/FR1998/001438 WO1999001132A1 (fr) | 1997-07-04 | 1998-07-06 | Medicament, contenant de la yohimbine et de l'arginine, destine a traiter les dysfonctions erectiles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE212841T1 true ATE212841T1 (de) | 2002-02-15 |
Family
ID=9508874
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98935102T ATE212841T1 (de) | 1997-07-04 | 1998-07-06 | Yohimbine und arginin enthaltende zusammensetzung zur behandlung der erektilen fehlfunktion |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20020155136A1 (de) |
| EP (1) | EP1001775B1 (de) |
| JP (1) | JP2002511875A (de) |
| KR (1) | KR20010021505A (de) |
| CN (1) | CN1261798A (de) |
| AT (1) | ATE212841T1 (de) |
| AU (1) | AU743825B2 (de) |
| BR (1) | BR9810981A (de) |
| CA (1) | CA2295916A1 (de) |
| DE (1) | DE69803773T2 (de) |
| DK (1) | DK1001775T3 (de) |
| ES (1) | ES2172171T3 (de) |
| FR (1) | FR2765483B1 (de) |
| ID (1) | ID24184A (de) |
| IL (1) | IL133443A0 (de) |
| PT (1) | PT1001775E (de) |
| WO (1) | WO1999001132A1 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6294517B1 (en) | 1996-02-02 | 2001-09-25 | Nitromed, Inc. | Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use |
| US6469065B1 (en) | 1996-02-02 | 2002-10-22 | Nitromed, Inc. | Nitrosated and nitrosylated α-adrenergic receptor antagonist, compositions and methods of use |
| US6323211B1 (en) | 1996-02-02 | 2001-11-27 | Nitromed, Inc. | Compositions and methods for treating sexual dysfunctions |
| US6472425B1 (en) | 1997-10-31 | 2002-10-29 | Nitromed, Inc. | Methods for treating female sexual dysfunctions |
| DE19831263A1 (de) * | 1998-07-11 | 2000-01-13 | Lohmann Therapie Syst Lts | Darreichungsform |
| AU762934B2 (en) * | 1999-09-03 | 2003-07-10 | Allergan Sales, Llc | Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction |
| PT1086695E (pt) * | 1999-09-21 | 2005-05-31 | Enzo Leone | Composicoes antivirais que compreendem ioimbina como principio activo |
| US6565851B2 (en) * | 2000-05-26 | 2003-05-20 | Horphag Research Limited | Relieving symptoms of erectile dysfunction with proanthocyanidins |
| KR20010016165A (ko) * | 2000-11-16 | 2001-03-05 | 정순학 | 성기능 장애 치료를 위한 피부에 적용하는 제제 |
| ITMI20020990A1 (it) * | 2002-05-10 | 2003-11-10 | Indena Spa | Formulazioni utili nel trattamento dell'impotenza maschile e femminile |
| ITMI20020994A1 (it) * | 2002-05-10 | 2003-11-10 | Indena Spa | Formulazioni utili nel trattamento dell'impotenza maschile e femminile |
| HUP0401422A2 (en) | 2004-07-15 | 2006-04-28 | G Laszlo Meszaros | Use of l-arginine as vasoaktive ingredient absorbing through skin for external application |
| DE102005053241A1 (de) * | 2005-11-08 | 2007-05-16 | Schwabe Willmar Gmbh & Co | Extrakte aus der Rinde von Corynanthe-Arten und deren Verwendung sowie diese Extrakte enthaltende Arzneimittel, diätetische Lebensmittel und pharmazeutische Zubereitungen |
| CN111840508A (zh) * | 2020-07-17 | 2020-10-30 | 北京清大赛尔生物科技有限公司 | 一种预防及治疗男性性功能障碍的外用制剂及其应用 |
| CN113116905A (zh) * | 2021-04-20 | 2021-07-16 | 北京天玺宝科技有限公司 | 一种增强男性性功能并持续改善性功能障碍的组合物及其制备方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5565466A (en) * | 1993-08-13 | 1996-10-15 | Zonagen, Inc. | Methods for modulating the human sexual response |
-
1997
- 1997-07-04 FR FR9708504A patent/FR2765483B1/fr not_active Expired - Fee Related
-
1998
- 1998-07-06 BR BR9810981-2A patent/BR9810981A/pt not_active IP Right Cessation
- 1998-07-06 KR KR1020007000035A patent/KR20010021505A/ko not_active Application Discontinuation
- 1998-07-06 PT PT98935102T patent/PT1001775E/pt unknown
- 1998-07-06 DK DK98935102T patent/DK1001775T3/da active
- 1998-07-06 ID IDW20000221A patent/ID24184A/id unknown
- 1998-07-06 AT AT98935102T patent/ATE212841T1/de not_active IP Right Cessation
- 1998-07-06 CN CN98806755A patent/CN1261798A/zh active Pending
- 1998-07-06 EP EP98935102A patent/EP1001775B1/de not_active Expired - Lifetime
- 1998-07-06 DE DE69803773T patent/DE69803773T2/de not_active Expired - Fee Related
- 1998-07-06 WO PCT/FR1998/001438 patent/WO1999001132A1/fr not_active Application Discontinuation
- 1998-07-06 CA CA002295916A patent/CA2295916A1/en not_active Abandoned
- 1998-07-06 ES ES98935102T patent/ES2172171T3/es not_active Expired - Lifetime
- 1998-07-06 IL IL13344398A patent/IL133443A0/xx unknown
- 1998-07-06 US US09/462,143 patent/US20020155136A1/en not_active Abandoned
- 1998-07-06 JP JP50655099A patent/JP2002511875A/ja active Pending
- 1998-07-06 AU AU84467/98A patent/AU743825B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010021505A (ko) | 2001-03-15 |
| DK1001775T3 (da) | 2002-04-29 |
| AU743825B2 (en) | 2002-02-07 |
| IL133443A0 (en) | 2001-04-30 |
| AU8446798A (en) | 1999-01-25 |
| EP1001775B1 (de) | 2002-02-06 |
| FR2765483A1 (fr) | 1999-01-08 |
| EP1001775A1 (de) | 2000-05-24 |
| JP2002511875A (ja) | 2002-04-16 |
| CA2295916A1 (en) | 1999-01-14 |
| BR9810981A (pt) | 2000-08-15 |
| FR2765483B1 (fr) | 2000-02-04 |
| DE69803773T2 (de) | 2002-08-29 |
| PT1001775E (pt) | 2002-07-31 |
| DE69803773D1 (de) | 2002-03-21 |
| ES2172171T3 (es) | 2002-09-16 |
| CN1261798A (zh) | 2000-08-02 |
| WO1999001132A1 (fr) | 1999-01-14 |
| ID24184A (id) | 2000-07-13 |
| US20020155136A1 (en) | 2002-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE212841T1 (de) | Yohimbine und arginin enthaltende zusammensetzung zur behandlung der erektilen fehlfunktion | |
| ATE383169T1 (de) | Komponente und zusammensetzungen zur verabreichung von wirkstoffen | |
| DE69727158D1 (de) | Pharmazeutische zusammensetzungen enthaltend eine mischung von selbstvernetzter und nichtselbstvernetzter hyaluronsäure zur behandlung von arthropathien | |
| DE69803360T2 (de) | Anwendungsformen zur behandlung der männlichen erektilen dysfunktion | |
| DE69531741D1 (de) | Verbindungen und zusammensetzungen zur verabreichung aktiver stoffe | |
| DK0776202T3 (da) | Liposomalt indkapslet taxol, dets fremstilling af dets anvendelse | |
| ATE399553T1 (de) | Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen | |
| TR200102648T2 (tr) | Büyümeyi destekleyen bileşimler | |
| ATE241353T1 (de) | Fumarsäurederivate zur behandlung der transplantatabstossung | |
| ATE211384T1 (de) | Verwendung von adenosinantagonisten zur vorbeugung und behandlung von pankreatitis und ulcera | |
| ATE311373T1 (de) | Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen | |
| MX9702170A (es) | Uso de inhibidores de la aromatasa para la produccion de un agente farmaceutico para el tratamiento de una deficiencia de androgeno relativa en los hombres. | |
| ATE186834T1 (de) | Verwendung von wirksamen mengen von aktiven stoffen zur behandlung von mischhaut | |
| NZ505742A (en) | Compositions containing aminobiguanides with antimicrobial activity used to treat contact lenses | |
| ATE152628T1 (de) | Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft | |
| ATE104551T1 (de) | S-adenosylmethionin zur behandlung von pankreatitis und der immunabstossung des pankreastransplantates. | |
| RS50148B (sr) | Upotreba docetaksela za lečenje hepatoćelijskog karcinoma | |
| DE3582594D1 (de) | Proglumid und dessen pharmazeutische zusammensetzungen zur anwendung bei der behandlung von neoplastischen affektionen. | |
| DE69939075D1 (de) | Pharmazeutische Zusammenstellung zur Vorbeugung und Behandlung von mit Zellkrankheiten des Augenhintergrundes zusammenhängenden Krankheiten | |
| ATE359808T1 (de) | Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma | |
| ATE548048T1 (de) | Oncomodulin zur behandlung von neurologishen erkrankungen | |
| ATE193206T1 (de) | Zusammensetzung zur behandlung oder vorbeugung von herpes | |
| DE60107900D1 (de) | Pharmazeutische Zusammensetzung und Nahrungsmittel zur Behandlung von Gehirnödem | |
| ATE291425T1 (de) | R-eliprodil zur behandlung von glaucoma | |
| ATE236633T1 (de) | Topische verwendung von loperamid zur behandlung mikrobieller infektionen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |